Bobak Azamian

Bobak Azamian

Verkställande Direktör på TARSUS PHARMACEUTICALS, INC.

Förmögenhet: 55 M $ per 2026-06-30

48 år
Health Technology
Consumer Services
Finance

Profil

Bobak Azamian was the founder of Metavention, Inc., founded in 2012, where the title held was President & Chief Medical Officer in 2018.
Dr. Azamian is the founder of Tarsus Pharmaceuticals, Inc., founded in 2017, holding the titles of Chairman, President & Chief Executive Officer since 2022.
Dr. Azamian is the founder of Vibrato Medical, Inc., founded in 2016, serving as Director.
Dr. Azamian is also the founder of Novel Therapeutics Co...
Dr. Azamian currently serves as Director at Osanni Bio, Inc. since 2022.
Former positions include Director at OCTANe, Principal at Amgen, Inc., Principal at Versant Venture Management LLC, and Senior Associate at Third Rock Ventures LLC.
Education includes a doctorate from the University of Oxford, an undergraduate degree from William Marsh Rice University, and a doctorate from Harvard Medical School.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-06-17 881 412 ( 2,05 % ) 55 M $ 2026-06-30

Aktiva positioner av Bobak Azamian

FöretagPositionStart
TARSUS PHARMACEUTICALS, INC. Verkställande Direktör 2018-09-01
Grundare 2016-12-01

Tidigare kända positioner av Bobak Azamian

FöretagPositionSlut
Verkställande Direktör 2018-01-01
Novel Therapeutics Co.
Grundare -
Direktör/Styrelseledamot -
Privat kapitalinvesterare -
AMGEN INC. Företagsledare/Principal -
Se detaljerna i Bobak Azamians erfarenhet

Bobak Azamians utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

8

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Health Technology

Consumer Services

Consumer Services

Finance

Finance

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Novel Therapeutics Co.

  1. Börsen
  2. Insiders
  3. Bobak Azamian